Insider Transactions in Q3 2021 at Travere Therapeutics, Inc. (TVTX)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 14
2021
|
Brinkley Ruth Williams |
BUY
Grant, award, or other acquisition
|
Direct |
5,250
+50.0%
|
-
|
|
Aug 17
2021
|
Laura Clague Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,407
-4.3%
|
$23,919
$17.12 P/Share
|
|
Aug 17
2021
|
Elizabeth E Reed SVP, GC & CORPORATE SECRETARY |
SELL
Open market or private sale
|
Direct |
1,407
-3.61%
|
$23,919
$17.12 P/Share
|
|
Aug 17
2021
|
William E. Rote SENIOR VICE PRESIDENT, R&D |
SELL
Open market or private sale
|
Direct |
1,407
-3.79%
|
$23,919
$17.12 P/Share
|
|
Aug 17
2021
|
Noah L. Rosenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,407
-2.87%
|
$23,919
$17.12 P/Share
|
|
Aug 17
2021
|
Eric M Dube CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
7,836
-4.76%
|
$133,212
$17.12 P/Share
|
|
Aug 17
2021
|
Peter Heerma CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,407
-2.17%
|
$23,919
$17.12 P/Share
|
|
Aug 13
2021
|
Laura Clague Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,500
+12.09%
|
-
|
|
Aug 13
2021
|
Elizabeth E Reed SVP, GC & CORPORATE SECRETARY |
BUY
Grant, award, or other acquisition
|
Direct |
4,500
+10.36%
|
-
|
|
Aug 13
2021
|
William E. Rote SENIOR VICE PRESIDENT, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
4,500
+10.81%
|
-
|
|
Aug 13
2021
|
Noah L. Rosenberg Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,500
+8.41%
|
-
|
|
Aug 13
2021
|
Eric M Dube CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
17,500
+9.6%
|
-
|
|
Aug 13
2021
|
Peter Heerma CHIEF COMMERCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
4,500
+6.48%
|
-
|
|
Jul 28
2021
|
Noah L. Rosenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,250
-2.73%
|
$16,250
$13.81 P/Share
|
|
Jul 16
2021
|
Steve Aselage Director |
BUY
Bona fide gift
|
Indirect |
3,000
+9.68%
|
-
|
|
Jul 16
2021
|
Steve Aselage Director |
SELL
Bona fide gift
|
Direct |
3,000
-1.82%
|
-
|